Asthma and allergy

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
Nora Drick, Jan Fuge, Benjamin Seeliger, Milan Speth, Jens Vogel-Claussen, Tobias Welte, Hendrik Suhling

ERJ Open Research Oct 2022, 8 (4) 00207-2022; DOI: 10.1183/23120541.00207-2022
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic, Renaud Louis

ERJ Open Research Oct 2022, 8 (4) 00273-2022; DOI: 10.1183/23120541.00273-2022
Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance
Antoine Beurnier, Youri Yordanov, Agnès Dechartres, Aurélien Dinh, Erwan Debuc, François-Xavier Lescure, Patrick Jourdain, Luc Jaulmes, Marc Humbert

ERJ Open Research Oct 2022, 8 (4) 00012-2022; DOI: 10.1183/23120541.00012-2022
Body mass index increase: a risk factor for forced expiratory volume in 1 s decline for overweight and obese adults with asthma
Nicolás Bermúdez Barón, Hannu Kankaanranta, Linnea Hedman, Martin Andersson, Caroline Stridsman, Anne Lindberg, Eva Rönmark, Helena Backman

ERJ Open Research Oct 2022, 8 (4) 00110-2022; DOI: 10.1183/23120541.00110-2022
It is time to end our love affair with short-acting β₂-agonists in asthma
Michael G. Crooks, Shoaib Faruqi

ERJ Open Research Oct 2022, 8 (4) 00353-2022; DOI: 10.1183/23120541.00353-2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Håkansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg

ERJ Open Research Oct 2022, 8 (4) 00238-2022; DOI: 10.1183/23120541.00238-2022
Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
Johannes A. Kroes, Aruna T. Bansal, Emmanuelle Berret, Nils Christian, Andreas Kremer, Anna Alloni, Matteo Gabetta, Chris Marshall, Scott Wagers, Ratko Djukanovic, Celeste Porsbjerg, Dominique Hamerlijnck, Olivia Fulton, Anneke ten Brinke, Elisabeth H. Bel, Jacob K. Sont

ERJ Open Research Oct 2022, 8 (4) 00168-2022; DOI: 10.1183/23120541.00168-2022
Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study
Barbara Bonnesen, Pradeesh Sivapalan, Anna Kjær Kristensen, Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Ema Rastoder, Rikke Sørensen, Josefin Eklöf, Tor Biering-Sørensen, Jens-Ulrik Stæhr Jensen

ERJ Open Research Jul 2022, 8 (3) 00200-2022; DOI: 10.1183/23120541.00200-2022
Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma
Fatemeh Moheimani, Nafeesa Shahdab, Stephen Cummings, Philip M. Hansbro, Christopher Ward

ERJ Open Research Jul 2022, 8 (3) 00314-2022; DOI: 10.1183/23120541.00314-2022
Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma
Elisa Franceschi, Nora Drick, Jan Fuge, Tobias Welte, Hendrik Suhling

ERJ Open Research Jul 2022, 8 (3) 00138-2022; DOI: 10.1183/23120541.00138-2022

Main menu

User menu

Search

Asthma and allergy

Pages

Contact us